Introduction {#sec1-1}
============

Infertility as a medical and social problem has acquired global dimension, and its incidence is supposed to be increasing day by day every decade.\[[@ref1]\] Nature is always doing better for all living being; but due to the present lifestyle, there has been a drastic change in day-to-day activities including lifestyle, food habits, sexual life, environmental pollution, industrial and occupational hazards and these changes have adverse effect on *Shukra* *Dhatu* which leads to infertility. Infertility affects 10% of couples, usually as a result of asymptomatic infection. Poverty, nutrition and pollution are problems that must also be tackled. One such factor is the role of low sperm count in male infertility and its management. The most cost-effective approach to solve the infertility problems is prevention and education. Infertility is defined as inability to conceive after a year of sexual intercourse without the use of contraceptives. A male contributory factor is involved in approximately half of these cases,\[[@ref2]\] but most of the causes for reduced semen quality and other disturbances of male reproductive function are unknown.\[[@ref3]\] Oligozoospermia is termed as *Ksheena* *Shukra* in Ayurvedic text which indicates low volume and less number of spermatozoa in seminal fluid.

The principle of treatment for depletion of tissue (*Dhatu* *Kshaya*) is to administer the drugs, which are having the same qualities of that *Dhatu*. *Drugs* having properties like *Madhura* (sweet), *Sheeta* (cold) and *Snigdha* (unctuous) are effective in enhancing the quality and quantity of *Shukra* *Dhatu*.\[[@ref4]\] *Ghrita* also possess similar properties, that is *Madhura*, *Sheeta* and *Snigdha*, and thus helps to increase semen parameters. *Ghrita* is best among all *Sneha* used internally and helps for digestion, absorption and delivery of drugs processed in it, to a target organ system.

Further, it is mentioned in Ayurveda texts that it is essential to perform *Shodhana* (biopurification) procedure before administering the *Vajikarana* (aphrodisiac) drugs. Only then *Brimhana* (nourising) and *Balya* (gives strength/power/stemina) effect of *Vajikarana* are achieved. It is clearly stated that without *Shodhana*, *Vajikarana* treatment is of no use. *Shodhana* procedures mainly *Virechana* are described for the management of *Shukra* *Dosha*.\[[@ref5]\]

Aims and objectives {#sec2-1}
-------------------

The objective was to evaluate the efficacy of *Virechana* followed by oral administration of *Go-Ghrita* in the management of *Ksheena* *Shukra* (oligozoospermia).

Materials and Methods {#sec1-2}
=====================

For the clinical study, 42 male patients suffering from primary or secondary infertility for \>1 year and having sperm count \<15 million/ml and willing to participate in the clinical trial were selected irrespective of religion and caste from the outpatient department of *Kayachikitsa* or referred from *Prasuti* *Tantra* and *Streeroga* department of IPGT&RA hospital. Permission was obtained from the Institutional Ethics Committee of the institute; vide Ref-PGT/7/-A/ethics/2015-16/2675, dated: December 11, 2015, and the study was also registered in Clinical Trials Registry-India (CTRI) (vide CTRI//20164/01/006559). Informed consent was obtained from all the participants before including them in the present study.

Inclusion criteria {#sec2-2}
------------------

Male patients with a age group of 21--40 years having sperm count \<15 million/ml\[[@ref6]\] and eligible for the procedure of *Virechana* were included for the present clinical trial.

Exclusion criteria {#sec2-3}
------------------

Male patient of age below 21 and above 40 years having sperm count \>15 million/ml, patient of azoospermia and aspermia or suffering from varicocele, accessory sex gland infection, sexually transmitted diseases and severe systemic diseases were excluded from the study. Patients who had genetic disorders such as Klinefelter's syndrome or taking treatment for major psychiatric illness, history of previous medications, and trauma, leading to oligozoospermia and the patient not eligible for *Virechana* were also excluded from the present clinical trial.

Laboratory investigation {#sec2-4}
------------------------

### Semen analysis {#sec3-1}

Semen analysis was carried out on registering the patients, which was taken as the baseline and thereafter, it was repeated after *Samsarjana* *Krama* (dietary regimen after *Virechana*) and on the 8 weeks of the oral treatment with *Go-Ghrita*. Serum follicle-stimulating hormone (FSH), serum luteinizing hormone (LH) and serum testosterone were taken as biomarkers and these tests were done before and after the treatment in selected patients due to budgetary provision. Routine hematological and urine examination were carried out to assess the status of the patients and to exclude other pathologies. In suspected cases, ultrasonography of abdomen and pelvis was done to rule out hydrocele, varicocele and other pathologies that are secondary cause of oligoospermia, before including the patients in present clinical trial.

Methods {#sec2-5}
-------

### Posology {#sec3-2}

Before administration of *Go-Ghrita*, *Virechana* *Karma* was performed. The details of drugs used for *Virechana* *Karma* are mentioned in [Table 1](#T1){ref-type="table"}. For the present clinical trial, *Go-Ghrita*, was procured from Khadi Gramodyog, Jamnagar and authenticated in the pharmacognosy Laboratory of the institute. All other drugs used in the *Virechana* process were procured from pharmacy of Gujarat Ayurved University, Jamnagar.

###### 

Details of *Virechana Karma*

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Procedure                                                               Drug and dosage                                                                                               Duration
  ----------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------- -----------------
  *Deepana* and *Pachana* (stimulation of digestion)                      *Trikatu Churna* (*Shunthi, Maricha, Pippali*) 2 g/thrice a day with warm water after meal                    3-4 days

  *Snehapana*                                                             *Go-Ghrita* (cow *ghee*) (as per\                                                                             3-7 days
                                                                          *Koshtha* and *Agni*) in increasing dose. Average initial dose was 30-40 ml and maximum dose was 260-280 ml   

  *Abhyanga* and *Vashpa Svedana* (body massage and swetation fomation)   *Bala Taila*, twice a day\                                                                                    3 days
                                                                          For *Vashpasveda Dashamoola*\                                                                                 
                                                                          *Kwatha* was used                                                                                             

  *Virechana Karma* (medicated purgation)                                 *Haritakyadi Yoga which contains*\                                                                            In average dose
                                                                          *Haritaki, Saindhava, Amalaki, Guda, Vacha, Vidanda, Rajani, Pippali*, *Shunthi*-in equal quantity 18 g       

  *Sansarjana Krama*                                                      Regulatory diet regimen as per\                                                                               3-7 days
                                                                          *Shuddhi* (purification)                                                                                      
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

### Method of Virechana Karma {#sec3-3}

Before administration of *Go-Ghrita*, all the registered patients were given *Virechana*. For this purpose, patients who met inclusion criteria and gave consent for the *Virechana* were administered *Trikatu* *Churna* for the first 3 days for *Deepana* and *Pachana* (stimulation of digestion) in the dose of 2 g twice in a day with lukewarm water after meal. On the 4^th^ day, after assessing the status of the patients, Cow *Ghrita*\[[@ref7]\] in the dose of 40 ml was given in the early morning on empty stomach with lukewarm water. The patients were observed for *Sneha* *Jeerna* *Lakhshana* (proper digestion of *Ghrita*) and accordingly for the next 5--7 days, the dose of *Ghrita* was given in increasing pattern till the patients achieved proper *Snehana* (internal oleation) features. After completion of internal *Snehana* for the next 3 days, whole-body massage with *Bala* *Taila* along with *Vashpa* *Swedana* was done daily once in the morning.\[[@ref8]\] During this period, patients were kept on a normal diet with precautions, to avoid excessive oil, or heavy food items. On the day of *Virechana*, after massage and fomentation in the morning, *Virechana* *Yoga* of *Haritakyadi* *Yoga* was given.

### Method of preparation of Haritakyadi Yoga {#sec3-4}

For the preparation of *Haritakyadi* *Yoga*,\[[@ref9]\] 18 g (each in same amount) of fine powder of *Haritaki* (*Terminalia* *chebula* Retz.), *Saindhava* (*Rock* *Salt*), *Amalaki* (*Emblica* *officinalis* Gaertn.), *Vacha* (*Acorus* *calamus* Linn.), *Vidanga* (*Embelia* *ribes* Burm. F.), *Rajani* (*Curcuma* *longa* Linn.), *Pippali* (*Piper* *longum* Linn.) and *Shunthi* (*Zingiber* *officinale* Rosc.) was taken. About 2 g of *Guda* (jaggery) was added to it. To this half glass of water was added and heated until it was lukewarm. This was given to patients on empty stomach.

Thereafter, according to the type of *Shuddhi*, at the end of *Virechana* procedure, 3, 5 and 7 days of post-*Virechana* dietary regimen for revival were advised which included *Peya* (thin gruel of rice), *Vilepi* (thick gruel of rice), *Akrita* *Yusha* (nonprocessed soup of vegetables/pulses) and *Krita* *Yusha* (processed with *Ghrita*, salt and pepper, soup of vegetables/pulses) in a sequential pattern.\[[@ref10]\]

After completion of *Virechana*, *Go-Ghrita* was administered for 8 weeks in the dose 10 gm twice a day after meal with a cup of milk and patients were asked to report fortnightly and on every visit, the details regarding the status were recorded.

### Criteria for assessment {#sec3-5}

The efficacy of the treatment was assessed on the basis of improvement in the subjective as well as objective parameters.\[[@ref11]\] For the subjective parameters, an appropriate scoring pattern was adopted for parameters such as sexual desire, erection, rigidity, performance anxiety, ejaculation, orgasm, overall satisfaction, erectile function and post act-exhaustion. The scoring pattern assessed before and after the completion of treatment is shown in [Appendix 1](#App1){ref-type="app"}.

### Objective parameters {#sec3-6}

Improvement in the semenogram was observed, especially on the total sperm count. Changes in serum FSH, serum LH and serum testosterone were also considered for assessment and they were assessed in comparison to the baseline score in all patients.

Statistical analysis {#sec2-6}
--------------------

General data was subjected to suitable statistical analysis such as descriptive statistics for demographic data, Wilcoxon signed-rank test for nonparametric paired data and paired *t*-test for quantitative parametric paired data.

After preparing the master chart of all the required data in the Microsoft Excel worksheet, statistical calculations were made with the help of Sigma Stat 3.5 software and In Stat 3 software product software by Aspire software international. The results were interpreted as significant (*P* \< 0.05), highly significant (*P* \< 0.01), very highly significant (*P* \< 0.001) and insignificant (*P* \> 0.05).

Observation on demographic data {#sec2-7}
-------------------------------

A total of 42 male patients of oligozoospermia (*Ksheena* *Shukra*) were registered for the present study, of which 38 patients completed the full course of treatment, and four patients dropped out as they did not timely report for the follow-up. In the study, the maximum number of patients (47.61%) were in the age group of 21--30 years, belonged to the Hindu religion (95.23%) and 47.61% had secondary education. Nearly, 61.90% of the patients were from urban area and were belonging to poor socioeconomic class (59.52%) and 45.23% of them were laborer by occupation.

Around 53.44% of the patients were doing heavy physical exertion, 59.52% of the patients in the present trial had *Vishama* *Agni* (irregular digestive process), 50% of patients had irregular dietary habits, 78.57% of the patients had the habit of taking frequent hot water bath and 95.32% of the patients were wearing tight undergarment. About 47.61% of the patients had the habit of chewing tobacco followed by 30.95% having addiction of smoking cigarette, 38.09% of the patients were having reduced and disturbed sleep and 52.38% of the patients were suffering from negative psychological emotions such as stress and worry (35.71).

The 47.61% of the patients had *Vata-Pitta* *Prakriti* and were having *Madhyama* *Bala*. About 95.23% of the patients were in the habit of taking *Lavana* (salt) predominant diet. Almost 78.79% of the patients had history of consumption of spicy food, 97.61% of the patients had primary infertility, while 2.38% of the patients had secondary infertility, 78.49% of the patients reported exertion during intercourse, followed by 26.88% of patients with less motivation, 78.57% of the patients complaint of loss of sexual desire, 88.90% of patients with general debility and 50% of the patients had low semen volume and premature ejaculation.

Results {#sec1-3}
=======

Effect on seminal parameters {#sec2-8}
----------------------------

*Go-Ghrita* administered after *Virechana* (medicated purgartion) provided increase of 80.92%, on total sperm count, 41.78% increase in sperm motility, 12.58% increase in normal form of total sperm, 41.69% decrease in abnormal forms, and increase in semen volume by 45.22%. Further analysis revealed when the effect was assessed for the period of before treatment and after *Samsarjan* *Krama* i.e. after the completion of *Virechana* procedure 68.87% increase in total sperm count was found 37.76% increase in total sperm count was found when the effect was assessed for the period between *Samsarjana* *Karma* and after the treatment i.e. eight weeks of treatment with oral administration of *Go-Ghrita*.

In sperm motility, before treatment and after *Samsarjan* *Krama*, 38.55% increase was found. When assessed between after completion of *Samsarjana* *Krama* and after completion of treatment, 15.09% increase in sperm motility was found. Before treatment and after, assessment of *Samsarjan Krama* revealed that cow *Ghrita* provided 9.85% increase in normal sperm count. After *Samsarjana* *Krama* and after treatment, the therapy provided 4.60% increase in normal sperm count.

Similarly, the analysis of the result showed that during before treatment and *Samsarjan* *Krama* decrease in abnormal form was 27.88%. After *Samsarjana* *Krama* and after completion of treatment provided decrease in abnormal form of sperm of 24.85% \[[Table 2](#T2){ref-type="table"}\].

###### 

Effect of therapies on seminal parameters

  Seminal parameters *n*=38   Mean value (million/ml)   Difference   Percentage   Paired *t*-test   Significance                              
  --------------------------- ------------------------- ------------ ------------ ----------------- -------------- ------ --------- --------- ----
  Total sperm count           9.42                      55.50        46.08        80.92↑            26.72          4.34   10.62     \<0.001   HS
  BT: 12.18                   AS: 39.422                27.14        68.87↑       26.89             4.15           7.21   \<0.001   HS        
  AS: 40.28                   AT: 55.50                 15.21        37.76↑       32.47             5.27           2.89   \<0.001   HS        
  Sperm motility              BT: 41.18                 AT: 68.15    20.78        ↑41.78            20.78          3.37   8.02      \<0.001   HS
  BT: 41.18                   AS: 59.21                 18.02        ↑38.55       17.06             2.73           6.51   \<0.001   HS        
  AS: 59.21                   AT: 68.16                 8.94         ↑15.09       16.45             2.66           3.35   \<0.002   HS        
  Normal sperm form           BT: 79.82                 AT: 90.13    10.31        ↑12.58            6.43           1.04   9.88      \<0.001   HS
  BT: 79.81                   AS: 86.15                 6.34         ↑9.85        6.46              1.05           6.05   \<0.001   HS        
  AS: 86.16                   AT: 90.13                 3.97         ↑4.60        4.64              6.76           5.21   \<0.001   HS        
  Abnormal form of sperm      BT: 19.52                 AT: 14.78    4.74         ↓41.69            11.08          1.79   2.64      \<0.01    S
  BT: 17.00                   AS: 14.78                 2.21         27.88↓       6.92              1.12           1.96   \<0.057   IS        
  AS: 21.30                   AT: 17.14                 4.16         ↓24.85       8.93              1.27           3.26   \<0.002   HS        
  Semen volume                BT: 1.45                  AT: 2.47     1.02         ↑45.22            2.32           0.37   2.72      \<0.001   HS
  BT: 1.45                    AS: 2.00                  0.56         ↑40.55       0.52              0.84           6.64   \<0.001   HS        
  AS: 2.00                    AT: 2.47                  0.47         ↑19.02       2.63              0.33           1.44   \<0.158   IS        

BT: Before treatment, AT: After treatment, AS: After *Samsarjana Krama*, SD: Standard deviation, SE: Standard error, HS: Highly significant, IS: Insignificant, S: Significant, ↑: Increase, ↓: Decrease

Effect on hormones {#sec2-9}
------------------

*Go-Ghrita* administered after *Virechana* provided 17.38% increase in serum FSH, 26.63% increase in serum LH value and 25.84% increase in serum testosterone value. All these changes reported on hormones were statistically highly insignificant \[[Table 3](#T3){ref-type="table"}\].

###### 

Effect of therapies on hormones

  Hormones (*n*=20)   Mean value (ng/ml)   Difference   Percentage   Paired *t*-test (*n*=400)   Significance                            
  ------------------- -------------------- ------------ ------------ --------------------------- -------------- ------- ------ --------- ----
  FSH                 6.80                 8.79         1.99         17.38↑                      1.68           0.38    5.20   \<0.001   HS
  LH                  4.89                 6.40         1.51         26.63↑                      1.07           0.26    6.15   \<0.001   HS
  Testosterone        566.39               734.63       168.24       25.84↑                      153.27         35.11   4.79   \<0.001   HS

BT: Before treatment, AT: After treatment, SD: Standard deviation, SE: Standard error, HS: Highly significant, ↑: Increase, FSH: Follicle-stimulating hormone, LH: Luteinizing hormone

Effect on hematological parameters {#sec2-10}
----------------------------------

There was no statistically significant changes (*P* \> 0.05) in the hematological parameters such as hemoglobin, total red blood cell count, total leukocyte count, differential count and biochemical parameters such as fasting blood sugar, serum cholesterol, serum triglyceride, serum creatinine, blood urea and serum glutamic pyruvic transaminase. Although there is a change from pretest to posttest mean value of above parameters it was within the normal limits. This proves that there was no adverse effect of the treatment.

Effect of therapy on subjective criteria {#sec2-11}
----------------------------------------

*Go-Ghrita* administered after *Virechana* (medicated purgation) provided statistically highly significant (*P* \< 0.001) result on generalized debility (83.33%), sexual weakness (16.66%), sexual desire (78.02%), erectile dysfunction (75.71%), erectile rigidity (65.15%), orgasm function (72.72%), increase in overall satisfaction (81.74%), frequency of coitus (57.47%) and duration of coitus (43.27%) and ejaculatory function (57.47%) was found.

Overall effect of therapy {#sec2-12}
-------------------------

Assessment of overall effect of the therapy revealed that *Go-Ghrita* administered after *Virechana* *Karma* provided excellent response in six patients (15.78%) and these patients were able to impregnate their partner. Fifteen patients (39.47%) showed marked positive response, whereas thirteen patients (34.32%) had moderate positive response and four patients (10.52%) had mild positive response.

Discussion {#sec1-4}
==========

Infertility and problems of impaired fecundity have been a concern through ages and is also a significant clinical problem today, which affects 8%--12% of couple worldwide in addition to 30% to 40% of cases involving both male and female factors. Male factor is present in one-half of infertile couples.\[[@ref12]\] *Go-Ghrita* possess *Vrishya* (aphrodiasic), *Rasayana* (rejuvenation), *Vata* and *Pitta* pacifying effect and digestive action.\[[@ref13]\] It also contains Vitamin A, D, E and K. Among them, Vitamin A and E are antioxidants and are helpful in preventing oxidative injury to the body.\[[@ref14]\]

*Shodhana* procedures are to be performed before administration of *Vajikarana* drugs, especially *Virechana* *Karma* has been indicated in the cases of vitiated *Shukra*. Therefore, *Virechana* *Karma* was selected for the present study.

Previous study on oligozoospermia concluded that *Virechana* *Karma* should be performed before administration of *Vajikarana* drugs and better and early changes in total sperm count can be achieved by *Virechana* *Karma*. In this study, significant result in sperm count and reduction in abnormal form of sperm along with significant effect on serum LH hormone level was found.\[[@ref15]\]

Maximum patients in this study were from the age group of 21--30, that is, in third decade of life and had imbalanced *Agni*, mainly *Vishamagni* (digestion controlling system). Substance which can help to balance *Pitta*, also act on disturbed state of *Agni*. If *Jathragni* is normal, then all *Dhatus* and *Dhatvagni* (metabolism) perform properly, leading to formation of optimum *Rasa* and *Shukra* *Dhatu*.\[[@ref16]\]

*Go-Ghrita* administered by *Nasya*, helps to regulate hormonal balance at hypothalamus level. Hormonal imbalance is one of the most etiological factors of infertility. *Go-Ghrita* is also can bond with lipid-soluble nutrients and herbs to penetrate the lipid-based cell walls of the body. Thus, it increases the potency of certain herbs by carrying the active components to the interior of the cells, which helps to increase marrow, semen and immunity (*Ojas*).\[[@ref17]\] It alleviates *Vata-Pitta* *Dosha* which is main *Dosha* leading to *Ksheena* *Shukra*.\[[@ref18]\] *Go-Ghrita* also provided significant increase in STH, SFSH and S. Testaterone.

Causative factors primarily affect the hypothalamic--pituitary--gonadal axis, which results in disturbances of serum FSH, serum LH and serum testosterone and testicular damage causing reproductive failure and infertility. Hence, it is important to maintain hormones in its normal state. Concerted action of the two gonadotropins, FSH and LH are necessary for the production of male gametes in the testis. FSH and LH exert their effect by binding to plasma membrane receptors of the target cells.\[[@ref19]\] LH mainly functions to stimulate testosterone secretion from the Leydig cells of the testicle, while FSH stimulates sertoli cells to facilitate germ cell differentiation. Gonadotropin release is modulated by a variety of other signals, such as estradiol (a potent inhibitor of both LH and FSH release), and inhibition from the sertoli cell, which causes a selective decrease in FSH release. Decreased amount of LH production fails to initiate spermatogenesis, thus causing oligospermia due to secondary deficiency of testosterone.\[[@ref20]\]

Probable mode of action of *Virechana* and *Go-Ghrita* {#sec2-13}
------------------------------------------------------

*Vajikarana* drugs (aphrodisiac recipes) should be administered after purifying the body,\[[@ref19]\] i.e., proper *Shodhana* either by *Vamana* or *Virechana*. In this study, statistically significant increase in sperm count was found after the completion of *Virechana* *Karma* and hence, it is clear from the generated data that *Virechana* enhances the quantity level of *Shukra* definitely. This may be because *Virechana* *Karma* increases the bioavailability of drugs by opening channels and by improving the nutritional assimilation which may lead to increase serum LH level.

*Go-Ghrita* contains Vitamin A, D, E and K. Vitamin E is an anti-sterility Vitamin, Vitamin A and Vitamin E, both are antioxidant vitamin and helps to enhance spermatogenesis. Also, study has reported that vitamin D supplementation effect on circulating levels of testosterone and also its consistent effect was reported on semen quality.\[[@ref21]\] *Go-Ghrita* has *Madhura* (sweet), *Snigdha* (unctuous) and *Sheeta* (cold) quality and *Shukra* is also homologous with it. On the basis of the qualitative aspect also, *Ghrita* is *Rasayana* and useful in palliating *Vata* and *Pitta* which are the main culprit *Dosha* involved in *Ksheena* *Shukra*, that is, oligozoospermia.\[[@ref22]\]

*Shodhana* has direct effect on metabolism. As *Shukra* is a *Sara* of all *Dhatus*, if *Rasa* formation is not proper, then *Uttarottara* *Dhatu* (consequence tissue) will be nourished properly. By *Shodhana* as preoperative regimens, medicine is adequately substantiated.\[[@ref23]\] It also open the occluded channels in the body and thus enhances the quality and quantity of *Shukra*. *Go-Ghrita* helps in improving digestive strength by revitalizing secretion of enzymes. *Go-Ghrita* is easy to absorb and metabolize, as it contains low-chain fatty acids. Constipation can be cured with cow ghee. If one consumes a spoonful of *Go-Ghrita* mixed in lukewarm milk daily, it helps to healthy bowel habit daily, which causes to cure *Apana Vayu* vitiation, which is responsible for excretion of flatus, urine, stool and semen.\[[@ref24]\]

Conclusion {#sec1-5}
==========

*Go-Ghrita* administered after *Virechana* *Karma* provides statistically highly significant increase in total sperm count, sperm motility, normal form of sperm, volume of semen and significant decrease in abnormal form of sperm. Significant increase in serum testosterone, serum FSH and serum LH indicates that the combined therapy of *Virechana* followed by *Go-Ghrita* acts through hormonal pathway to improve seminal parameters. As *Go-Ghrita* has provided significant result on seminal parameters, thus it can be choice of drug for the management of oligozoospermia. As *Virechna* *Karma* has also provided a significant increase in total sperm count and improved the quality of semen, it can also concluded that *Virechana* *Karma* alone is also effective in cases of oligozoospermia.
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###### 

Scoring pattern adopted for sexual parameters

  Symptoms                                                        Grade                                              Score
  --------------------------------------------------------------- -------------------------------------------------- -------
  Sexual desire                                                   No desire at all                                   3
  Lack of desire                                                  2                                                  
  Occasional desire only on demand of partner                     1                                                  
  Self and partner normal desire                                  0                                                  
  Erectile function                                               No erection or swelling without any methods        5
  Erection with artificial method                                 4                                                  
  Very slight swelling but unable to penetrate                    3                                                  
  Some swelling, able to penetrate                                2                                                  
  Erection with occasional failure                                1                                                  
  Full swelling whenever desire                                   0                                                  
  Ejaculatory function                                            On mere thoughts/slight or no ejaculation at all   4
  During foreplay before penetration                              3                                                  
  During sexual intercourse \<30 s/at least 1-5 pelvic thrusts    2                                                  
  During sexual intercourse \<60 s/at least 5-10 pelvic thrusts   1                                                  
  During sexual intercourse \>60 s/at least \>10 pelvic thrusts   0                                                  
  Overall satisfaction                                            No satisfaction after every act                    4
  Satisfaction in 25% act                                         3                                                  
  Satisfaction in 50% act                                         2                                                  
  Satisfaction in 75% act                                         1                                                  
  Satisfaction after every act                                    0                                                  
  Frequency of coitus (in weeks)                                  0                                                  3
  1-2                                                             2                                                  
  3-4                                                             1                                                  
  \>4                                                             0                                                  
  Scoring for associated symptoms                                                                                    
  *Daurbalya* (debility)                                          Cannot do any work                                 4
  Weakness and work affected                                      3                                                  
  Weakness but routine work not affected slight                   2                                                  
  Weakness                                                        1                                                  
  No weakness                                                     0                                                  
  *Mukha Shosha* (dryness of mouth)                               Dryness not relieved by anything                   2
  Dryness relieved by anything putting in mouth                   1                                                  
  No dryness of mouth                                             0                                                  
